Amgen recalls 60mg Sensipar tablets with CGMP deviations. This prescription medication may have quality issues affecting safety. Consumers should contact Amgen for details.
CGMP Deviations
Amgen is recalling 60mg Sensipar tablets that were made in Japan and distributed by Amgen. The recall is due to manufacturing deviations that could affect product safety.
The recall is for manufacturing deviations that could affect the product's safety. CGMP deviations refer to issues in the production process that may lead to quality problems. However, the specific risks are not detailed in the recall notice.
Prescription drug users who have the specific 60mg Sensipar tablets with NDC 55513-074-30 and lot number 1157055. People taking this medication for hypercalcemia are most at risk.
Check for Sensipar (cinacalcet) 60mg tablets in 30-count bottles. Look for the NDC code 55513-074-30 and lot number 1157055. These tablets were made in Japan and distributed by Amgen.
Reach out to Amgen directly for specific instructions on handling the recalled product.
The recall states there are manufacturing deviations, but does not specify if the product is safe to use. Consumers should contact Amgen for details.
The recall does not provide a specific remedy, so contact Amgen directly for instructions.
Check for the NDC code 55513-074-30 and lot number 1157055 on the product label. These tablets were made in Japan and distributed by Amgen.
We’ve drafted a message you can send Amgen to request your refund or repair — edit it as you like.
Subject: Recall D-0614-2026 — Amgen Amgen Hello, I own a Amgen that is covered by recall D-0614-2026 from Amgen. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
